• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用嵌合流感病毒对1型人类免疫缺陷病毒进行黏膜免疫的模型

Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus.

作者信息

Muster T, Ferko B, Klima A, Purtscher M, Trkola A, Schulz P, Grassauer A, Engelhardt O G, García-Sástre A, Palese P

机构信息

Institut für Angewandte Mikrobiologie, Universität für Bodenkultur, Vienna, Austria.

出版信息

J Virol. 1995 Nov;69(11):6678-86. doi: 10.1128/JVI.69.11.6678-6686.1995.

DOI:10.1128/JVI.69.11.6678-6686.1995
PMID:7474077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC189577/
Abstract

Previously, we constructed a chimeric influenza virus that expresses the highly conserved amino acid sequence ELDKWA of gp41 of human immunodeficiency virus type 1 (HIV-1). Antisera elicited in mice by infection with this chimeric virus showed neutralizing activity against distantly related HIV-1 isolates (T. Muster, R. Guinea, A. Trkola, M. Purtscher, A. Klima, F. Steindl, P. Palese, and H. Katinger, J. Virol. 68:4031-4034, 1994). In the present study, we demonstrated that intranasal immunizations with this chimeric virus are also able to induce a humoral immune response at the mucosal level. The immunized mice had ELDKWA-specific immunoglobulins A in respiratory, intestinal, and vaginal secretions. Sustained levels of these secretory immunoglobulins A were detectable for more than 1 year after immunization. The results show that influenza virus can be used to efficiently induce secretory antibodies against antigens from foreign pathogens. Since long-lasting mucosal immunity in the genital and intestinal tracts might be essential for protective immunity against HIV-1, influenza virus appears to be a promising vector for HIV-1-derived immunogens.

摘要

此前,我们构建了一种嵌合流感病毒,其表达人类免疫缺陷病毒1型(HIV-1)gp41的高度保守氨基酸序列ELDKWA。用这种嵌合病毒感染小鼠所诱导产生的抗血清,对亲缘关系较远的HIV-1分离株表现出中和活性(T. 穆斯特、R. 几内亚、A. 特科拉、M. 普尔切尔、A. 克利马、F. 施泰因德尔、P. 帕莱斯和H. 卡廷格,《病毒学杂志》68:4031 - 4034,1994年)。在本研究中,我们证明用这种嵌合病毒进行鼻内免疫也能够在黏膜水平诱导体液免疫反应。免疫后的小鼠在呼吸道、肠道和阴道分泌物中具有ELDKWA特异性免疫球蛋白A。免疫后1年多的时间里都能检测到这些分泌型免疫球蛋白A的持续水平。结果表明,流感病毒可用于有效诱导针对外来病原体抗原的分泌性抗体。由于生殖道和肠道中的持久黏膜免疫对于针对HIV-1的保护性免疫可能至关重要,流感病毒似乎是一种用于HIV-1衍生免疫原的有前景的载体。

相似文献

1
Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus.用嵌合流感病毒对1型人类免疫缺陷病毒进行黏膜免疫的模型
J Virol. 1995 Nov;69(11):6678-86. doi: 10.1128/JVI.69.11.6678-6686.1995.
2
Chimeric influenza virus replicating predominantly in the murine upper respiratory tract induces local immune responses against human immunodeficiency virus type 1 in the genital tract.主要在小鼠上呼吸道复制的嵌合流感病毒可诱导生殖道针对1型人类免疫缺陷病毒产生局部免疫反应。
J Infect Dis. 1998 Nov;178(5):1359-68. doi: 10.1086/314445.
3
Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.小鼠鼻内HIV-1-gp160-DNA/gp41肽初免-加强免疫方案可诱导产生长期的HIV-1中和性体液、黏膜及全身免疫。
J Immunol. 2004 Dec 1;173(11):7078-89. doi: 10.4049/jimmunol.173.11.7078.
4
Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.用表达来自HIV-1 gp41的一种肽的植物病毒进行鼻内免疫,比口服免疫能更好地刺激黏膜和全身的HIV-1特异性IgA和IgG。
J Immunol Methods. 1998 Nov 1;220(1-2):93-103. doi: 10.1016/s0022-1759(98)00145-8.
5
Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice.用捕获灭活HIV-1的纳米球进行黏膜免疫可在小鼠中诱导显著的HIV-1特异性阴道抗体反应。
J Med Virol. 2003 Feb;69(2):163-72. doi: 10.1002/jmv.10279.
6
A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus.一种新型重组腺相关病毒疫苗可诱导针对人类免疫缺陷病毒的长期体液免疫反应。
Hum Gene Ther. 2001 Jun 10;12(9):1047-61. doi: 10.1089/104303401750214276.
7
HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.艾滋病病毒黏膜疫苗:用包裹了gp160的日本血凝病毒-脂质体进行鼻腔免疫可诱导抗原特异性细胞毒性T淋巴细胞及中和抗体反应。
J Immunol. 2003 Jan 1;170(1):495-502. doi: 10.4049/jimmunol.170.1.495.
8
Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles.通过口服牛乳头瘤病毒-1型人类免疫缺陷病毒(HIV-1)gp41嵌合病毒样颗粒诱导针对HIV-1的黏膜和全身中和抗体。
J Virol. 2004 Aug;78(15):8342-8. doi: 10.1128/JVI.78.15.8342-8348.2004.
9
Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation.通过不同接种途径用1型人类免疫缺陷病毒A亚型病毒样颗粒免疫BALB/c小鼠诱导全身和黏膜跨亚型中和抗体。
J Virol. 2005 Jun;79(11):7059-67. doi: 10.1128/JVI.79.11.7059-7067.2005.
10
HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.用寡聚体gp160经鼻内免疫小鼠的生殖道和呼吸道中的HIV-1中和抗体。
J Immunol. 1998 Feb 15;160(4):2000-12.

引用本文的文献

1
Structural prediction of chimeric immunogen candidates to elicit targeted antibodies against betacoronaviruses.嵌合免疫原候选物的结构预测,以引发针对β冠状病毒的靶向抗体。
PLoS Comput Biol. 2025 Feb 5;21(2):e1012812. doi: 10.1371/journal.pcbi.1012812. eCollection 2025 Feb.
2
Influenza virus strains expressing SARS-CoV-2 receptor binding domain protein confer immunity in K18-hACE2 mice.表达新冠病毒受体结合域蛋白的流感病毒株可使K18-hACE2小鼠产生免疫力。
Vaccine X. 2024 Aug 3;20:100543. doi: 10.1016/j.jvacx.2024.100543. eCollection 2024 Oct.
3
Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines.迈向广谱保护:联合呼吸道病毒疫苗的开发与挑战。
Front Cell Infect Microbiol. 2024 Jun 5;14:1412478. doi: 10.3389/fcimb.2024.1412478. eCollection 2024.
4
Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants.鼻内单复制流感载体诱导针对SARS-CoV-2变体的交叉反应性血清和粘膜抗体。
Vaccines (Basel). 2023 Jun 5;11(6):1063. doi: 10.3390/vaccines11061063.
5
Structural prediction of chimeric immunogens to elicit targeted antibodies against betacoronaviruses.用于引发针对β冠状病毒的靶向抗体的嵌合免疫原的结构预测
bioRxiv. 2024 Sep 28:2023.01.31.526494. doi: 10.1101/2023.01.31.526494.
6
Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.用重组流感 A 病毒结核疫苗增强卡介苗可增加肺部 T 细胞反应,但不能预防结核分枝杆菌感染。
PLoS One. 2021 Nov 18;16(11):e0259829. doi: 10.1371/journal.pone.0259829. eCollection 2021.
7
A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model.一种基于单周期甲型流感病毒的新型冠状病毒2型疫苗在小鼠模型中引发强烈免疫反应。
Vaccines (Basel). 2021 Aug 3;9(8):850. doi: 10.3390/vaccines9080850.
8
Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice.黏膜佐剂增强的重组流感病毒载体疫苗在小鼠中诱导针对 HIV-1 的 T 细胞和抗体应答。
J Virol. 2021 May 24;95(12). doi: 10.1128/JVI.00059-21.
9
Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice.表达 SARS-CoV-2 受体结合域的减毒流感病毒粒子在小鼠中诱导中和抗体。
Viruses. 2020 Sep 5;12(9):987. doi: 10.3390/v12090987.
10
Attenuated influenza virions expressing the SARS-CoV-2 receptor-binding domain induce neutralizing antibodies in mice.表达严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域的减毒流感病毒粒子可在小鼠体内诱导中和抗体。
bioRxiv. 2020 Sep 3:2020.08.12.248823. doi: 10.1101/2020.08.12.248823.

本文引用的文献

1
Active and passive sensitization of the uterus of the cow in vivo against Trichomonas foetus antigen and the evidence for the local production of antibody in that site.牛子宫在体内对胎儿三毛滴虫抗原的主动和被动致敏以及该部位抗体局部产生的证据。
J Hyg (Lond). 1953 Sep;51(3):405-15. doi: 10.1017/s0022172400015825.
2
Protection against vaginal SIV transmission with microencapsulated vaccine.微囊化疫苗预防阴道内猴免疫缺陷病毒传播
Science. 1993 May 28;260(5112):1323-7. doi: 10.1126/science.8493576.
3
Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.通过鼻内应用链球菌表面蛋白抗原与霍乱毒素B亚单位诱导黏膜免疫。
Infect Immun. 1993 Jan;61(1):314-22. doi: 10.1128/iai.61.1.314-322.1993.
4
Expression of a foreign protein by influenza A virus.甲型流感病毒对外源蛋白的表达。
J Virol. 1994 Jul;68(7):4486-92. doi: 10.1128/JVI.68.7.4486-4492.1994.
5
New perspectives in vaccine development: mucosal immunity to infections.疫苗研发的新视角:针对感染的黏膜免疫
Infect Agents Dis. 1993 Apr;2(2):55-73.
6
Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus.利用哺乳动物内部核糖体进入位点元件通过转染流感病毒表达外源蛋白。
J Virol. 1994 Oct;68(10):6254-61. doi: 10.1128/JVI.68.10.6254-6261.1994.
7
Enteric immunization of mice against influenza with recombinant vaccinia.用重组痘苗对小鼠进行抗流感肠道免疫。
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11187-91. doi: 10.1073/pnas.91.23.11187.
8
Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.用同源或异源轮状病毒口服接种小鼠后,其黏膜和全身体液免疫反应及后续保护作用的比较。
J Virol. 1994 Dec;68(12):7766-73. doi: 10.1128/JVI.68.12.7766-7773.1994.
9
Mucosal immunity to infection with implications for vaccine development.黏膜感染免疫及其对疫苗研发的意义。
Curr Opin Immunol. 1994 Aug;6(4):572-83. doi: 10.1016/0952-7915(94)90144-9.
10
A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.一种针对1型人类免疫缺陷病毒gp41的广泛中和性人源单克隆抗体。
AIDS Res Hum Retroviruses. 1994 Dec;10(12):1651-8. doi: 10.1089/aid.1994.10.1651.